000 | 01939 a2200541 4500 | ||
---|---|---|---|
005 | 20250515071517.0 | ||
264 | 0 | _c20070813 | |
008 | 200708s 0 0 eng d | ||
022 | _a0269-9370 | ||
024 | 7 |
_a10.1097/QAD.0b013e32814e6b08 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHoffmann, Christopher J | |
245 | 0 | 0 |
_aHepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJun 2007 |
||
300 |
_a1301-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xanalysis |
650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
650 | 0 | 4 |
_aAspartate Aminotransferases _xanalysis |
650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHepatitis B _ximmunology |
650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOccupational Diseases _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSouth Africa _xepidemiology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTuberculosis _xcomplications |
700 | 1 | _aCharalambous, Salome | |
700 | 1 | _aThio, Chloe L | |
700 | 1 | _aMartin, Desmond J | |
700 | 1 | _aPemba, Lindiwe | |
700 | 1 | _aFielding, Katherine L | |
700 | 1 | _aChurchyard, Gavin J | |
700 | 1 | _aChaisson, Richard E | |
700 | 1 | _aGrant, Alison D | |
773 | 0 |
_tAIDS (London, England) _gvol. 21 _gno. 10 _gp. 1301-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/QAD.0b013e32814e6b08 _zAvailable from publisher's website |
999 |
_c17085127 _d17085127 |